BECTON, DICKINSON AND COMPANY Dividends Paid
BECTON, DICKINSON AND COMPANY (BDX) reported Dividends Paid of $875.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividends · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY payments of dividends for the quarter ending 2026-06-30 was $286.00M, a 4.35% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments of dividends for the quarter ending 2026-03-31 was $290.00M, a 2.68% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments of dividends for the quarter ending 2025-12-31 was $299.00M, a 0.99% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments of dividends for the quarter ending 2025-06-30 was $299.00M, a 8.73% increase year-over-year.
| Period end | Payments of Dividends 3 month | Payments of Dividends 6 month | Payments of Dividends 9 month |
|---|---|---|---|
| 2026-06-30 | $286.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $576.00M derived: sum of 2 quarters · filed 2026-08-06 | $875.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $290.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $589.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $299.00M 10-Q · filed 2026-02-09 | ||
| 2025-06-30 | $299.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $597.00M derived: sum of 2 quarters · filed 2026-08-06 | $899.00M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $298.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $600.00M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $302.00M 10-Q · filed 2026-02-09 | ||
| 2024-06-30 | $275.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $550.00M derived: sum of 2 quarters · filed 2025-08-07 | $825.00M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $275.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-01 | $550.00M 10-Q · filed 2025-05-01 | |
| 2023-12-31 | $275.00M 10-Q · filed 2025-02-06 | ||
| 2023-06-30 | $286.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01 | $568.00M derived: sum of 2 quarters · filed 2024-08-01 | $849.00M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $282.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-02 | $563.00M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $281.00M 10-Q · filed 2024-02-01 | ||
| 2022-06-30 | $271.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-03 | $541.00M derived: sum of 2 quarters · filed 2023-08-03 | $812.00M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $270.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-04 | $541.00M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $271.00M 10-Q · filed 2023-02-02 | ||
| 2021-06-30 | $261.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | $525.00M derived: sum of 2 quarters · filed 2022-08-04 | $789.00M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $264.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05 | $528.00M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $264.00M 10-Q · filed 2022-02-03 | ||
| 2020-06-30 | $268.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | $521.00M derived: sum of 2 quarters · filed 2021-08-05 | $773.00M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $253.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-06 | $505.00M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $252.00M 10-Q · filed 2021-02-04 | ||
| 2019-06-30 | $246.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $492.00M derived: sum of 2 quarters · filed 2020-08-06 | $737.00M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $246.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $491.00M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $245.00M 10-Q · filed 2020-02-06 | ||
| 2018-06-30 | $238.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-06 | $477.00M derived: sum of 2 quarters · filed 2019-08-06 | $687.00M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $239.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $449.00M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $210.00M 10-Q · filed 2019-02-05 | ||
| 2017-06-30 | $166.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $322.00M derived: sum of 2 quarters · filed 2018-08-02 | $478.00M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $156.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03 | $312.00M 10-Q · filed 2018-05-03 | |
| 2016-12-31 | $156.00M 10-Q · filed 2018-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |